ID: ALA5206108

Max Phase: Preclinical

Molecular Formula: C33H52N2O9

Molecular Weight: 620.78

Associated Items:

Representations

Canonical SMILES:  CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](CCNC(=O)OC(C)(C)C)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C

Standard InChI:  InChI=1S/C33H52N2O9/c1-20(9-12-27-21(2)17-26(23(4)42-27)35-29(37)14-11-22(3)41-24(5)36)10-13-28-30(38)33(19-40-33)18-25(43-28)15-16-34-31(39)44-32(6,7)8/h9-11,13-14,21-23,25-28,30,38H,12,15-19H2,1-8H3,(H,34,39)(H,35,37)/b13-10+,14-11-,20-9+/t21-,22-,23+,25+,26+,27-,28+,30+,33+/m0/s1

Standard InChI Key:  XBVZTXDANPJEPT-IGMWFBRCSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 620.78Molecular Weight (Monoisotopic): 620.3673AlogP: 3.89#Rotatable Bonds: 11
Polar Surface Area: 144.95Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.91CX Basic pKa: CX LogP: 2.61CX LogD: 2.61
Aromatic Rings: 0Heavy Atoms: 44QED Weighted: 0.14Np Likeness Score: 1.83

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source